MUKKA2026-10-27MUKKAMUKKA PROTEINS LIMITED544135NOTLISTEDINE0CG401037Key licenses or regulatory approvals (Sub-para 12-Para B)Newfalse2026-10-2712:30:002026-10-27Key licensesGrantingU.S. Food and Drug Administration (U.S. FDA). The certificate confirming registration has been issued by Registrar Corp, Virginia, USA.The Company has received a Certificate of Registration issued by Registrar Corp, Virginia, USA confirming the registration of the Company’s facility with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002 and the FDA Food Safety Modernization Act.The US FDA registration is expected to support the Company's business operations and facilitate its engagement with customers and markets requiring U.S. FDA facility registration.Grant of US FDA registration certificate confirms that it is registered with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002 and the FDA Food Safety Modernization Act.The US FDA registration is expected to support the Company's business operations and facilitate its engagement with customers and markets requiring U.S. FDA facility registration.. No immediate monetary impact can be quantified at this stage.Not Applicable.The Certificate is valid from the date of issuance, i.e. October 1, 2026, until December 31, 2027.The actual monetary impact cannot be quantified at this stage and will depend on the market acceptance and sales of the product. The registration is expected to facilitate marketability of the product in relevant markets.Not Applicable, as the disclosure relates to the grant of the US FDA registration and there has been no withdrawal, cancellation or suspension.The certificate of registration was uploaded by the Authority on their website and came to the knowledge of the Company on 27th October 2026 at 12:30 p.m.